Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB1 | P23443 | 12/20 | 0.48 |
| ▸ | ITGB2 | P05107 | 6/20 | 0.45 |
| ▸ | ICAM1 | P05362 | 6/20 | 0.45 |
| ▸ | ITGAL | P20701 | 6/20 | 0.45 |
| ▸ | AKT1 | P31749 | 11/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21434063 | 0.86 | RPS6KB1 (0.43) | RPS6KB1ITGB2ICAM1ITGALAKT1 | |
| SCHEMBL21433922 | 0.81 | ABL1 (0.41) | RPS6KB1ITGB2ICAM1ITGALAKT1 | |
| SCHEMBL21452865 | 0.79 | NPC1 (0.57) | RPS6KB1ITGB2ICAM1ITGALAKT1 | |
| SCHEMBL21452774 | 0.78 | ITGB2 (0.54) | RPS6KB1ITGB2ICAM1ITGALCYP1A2 | |
| SCHEMBL21434001 | 0.75 | ITGB2 (0.58) | RPS6KB1ITGB2ICAM1ITGAL | |
| SCHEMBL21452752 | 0.74 | ITGB2 (0.47) | RPS6KB1ITGB2ICAM1ITGAL | |
| SCHEMBL21453051 | 0.74 | ITGB2 (0.49) | RPS6KB1ITGB2ICAM1ITGAL | |
| SCHEMBL21452927 | 0.72 | ITGB2 (0.47) | RPS6KB1ITGB2ICAM1ITGAL | |
| SCHEMBL21434002 | 0.71 | GRM2 (0.35) | RPS6KB1AKT1 | |
| SCHEMBL21434102 | 0.68 | DPP4 (0.48) | RPS6KB1ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019193516-A2 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-10-10 | — | — | WO | disclosed |